PHARMACEUTICAL COMPOSITION INCLUDING 5-{4-(AMINOSULFONYL)PHENYL}-2,2-DIMETHYL-4-(3-FLUOROPHENYL)-3(2H)-FURANONE AND CAPSULE FORMULATION INCLUDING PHARMACEUTICAL COMPOSITION Russian patent published in 2019 - IPC A61K31/341 A61K47/38 A61K47/26 A61K47/12 A61K47/02 A61K9/48 A61P29/00 

Abstract RU 2681932 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: present invention relates to an anti-inflammatory pharmaceutical composition comprising 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone in crystalline form A, crystalline form G, or as a mixture of said crystalline forms, pharmaceutically acceptable diluent and pharmaceutically acceptable lubricant. Said active substance has a particle diameter of 50 % by volume (d(0.5)) from 3 to 9 microns. Diluent is selected from a group consisting of silicified microcrystalline cellulose, microcrystalline cellulose, cellulose, lactose, and combinations thereof, and the lubricant is talc or stearic acid. Pharmaceutical composition according to the present invention has advantages due to good stability, high dissolution rate, improved uniformity, as well as satisfactory pharmacokinetic properties.

EFFECT: due to these advantages, the pharmaceutical composition according to the present invention is effective in treating inflammation or pain.

8 cl, 10 dwg, 11 tbl, 11 ex

Similar patents RU2681932C2

Title Year Author Number
CRYSTALLINE AZITHROMYCIN L-MALATE MONOHYDRATE AND PHARMACEUTICAL COMPOSITION INCLUDING IT 2006
  • Kvon Bo Sung
  • Kim Eun Sook
  • Kim Khee Cheol
  • Jun Sangmin
  • Ko Mijang-Sil
  • Song Tae Khun
  • Kim Khan Kiong
  • Sukh Kvi Khiun
  • Li Gvansun
RU2348644C1
STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 2013
  • Kvon Taek Kvan
  • Kim Dong Kho
  • Kim Kieong Soo
  • Kim Jong Il
  • Park Dzae Khiun
  • Voo Dzong Soo
RU2614382C2
ISOLATED ORTHORHOMBIC CRYSTALLINE FORM OF 4-{6-ACETYL-3-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]-2-PROPYLPHENOXY}-BUTYRIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2004
  • Lok Kennet Uolter
  • Roi Dejvid Gregori
RU2317979C2
PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE 2005
  • Purkavoos Nazaneen
  • Nej Dzhejms R.
  • Krjuehjns Marija T.
  • Vu Jun'Khuehj
  • Palkar Saurabkh A.
RU2382648C2
CRYSTALLINE CLOPIDOGREL NAPHTALENE SULFONATE OR ITS HYDRATE, METHODS FOR ITS PRODUCING AND PHARMACEUTICAL COMPOSITION 2004
  • Jun Sangmin
  • Kim Eun Sook
  • Kim Khi Seok
  • Kvon Bo Sung
  • Kim Cheol Kiung
  • Kim Khan Kiong
  • Sukh Kvi-Khiun
  • Li Gvan Sun
RU2328501C1
NEW AMORPHOUS DISPERSION OF N'-(2-CHLOR-6-METHYL-BENZOYL)HYDRAZIDE OF 4-METHYL-3-QUINOLINE-3-YLETHYNYL-BENZOIC ACID 2018
  • Zala, Yashoradzh
  • Khanamannavar, Bramkhanand
  • Dkharmadkhikari, Nitin
RU2777569C2
PHARMACEUTICAL COMPOSITION 2011
  • Malkhotra Dzhina
  • Purandare Dr. Shrinivas Madkhukar
RU2589842C2
NEW CRYSTALLINE FORM OF 3-(4-(BENZYLOXY)PHENYL)HEX-4-ENOIC ACID DERIVATIVE 2020
  • Hwang, Jeong Un
  • Kim, Jin Woong
  • Lee, Kyu Hwan
  • Kim, Eun Young
  • Choi, Su Kyoung
RU2825215C2
PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN PREPARED WITHOUT GRANULATION 2004
  • Berkielli Al'Fred
  • Uoterman Kennet Krejg
  • Doehriti Patrik Dehvid
RU2314804C2
SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Lindemann, Christopher
  • Stengel, Peter J.
RU2772693C1

RU 2 681 932 C2

Authors

Kim Ben-Kha

An Sik Il

Pak Chzhe-En

Kim De Ren

Cho Chun Men

No Songu

Dates

2019-03-14Published

2015-01-29Filed